Study on Collaborative Care for Opioid and Alcohol Use Disorders
Overview of the Study
A recent study published in JAMA Internal Medicine investigates the impact of collaborative care on abstinence rates from opioid and alcohol use. Chronic substance use has significantly contributed to rising mortality rates associated with alcohol-related liver diseases and drug overdoses. Despite the prevalence of substance use disorders, these conditions often remain unrecognized and inadequately treated.
The Role of Primary Care in Treating Substance Use Disorders
Primary care is essential for addressing opioid and alcohol use disorders (OAUD). However, traditional specialty care alone is insufficient for meeting all treatment needs and is often limited in availability. Collaborative care aims to address these gaps by integrating behavioral health into primary care settings.
Benefits of Collaborative Care
Collaborative care is recognized as an effective method for enhancing the delivery of evidence-based treatments and improving patient outcomes. Nonetheless, its effectiveness in treating OAUD had not been thoroughly tested until now.
Research Methodology
The study, funded by the National Institute on Drug Abuse (NIDA), employed a randomized clinical trial design to evaluate the efficacy of collaborative care interventions for improving treatment outcomes in patients with OAUD. A total of 377 participants were recruited from June 3, 2014, to January 15, 2016, and monitored over a six-month period. Participants were randomly assigned to either a collaborative care approach (187 participants) or standard care (190 participants).
Collaborative Care Interventions
Participants in the collaborative care group received up to six psychotherapy sessions and/or medication-assisted treatments, including sublingual buprenorphine/naloxone for opioid use disorders and long-acting injectable naltrexone for alcohol use disorders. The collaborative care intervention employed a population-based management approach, measurement-based care, and integrated addiction expertise through a clinical psychologist affiliated with the Motivational Interviewing Network of Trainers.
Assessment and Support
Care coordinators met regularly with participants to assess motivation and encourage engagement with therapists for evaluation and treatment planning. They also conducted frequent assessments of substance use, documenting results in a participant registry for researcher review. Specialized therapists provided counseling support throughout the study.
Results and Implications
After six months, results indicated that a greater proportion of participants receiving collaborative care reported abstinence from opioids and alcohol compared to those receiving standard care. This suggests that a comprehensive approach, incorporating various aspects of healthcare—such as mental health, primary care, and counseling—is most effective in addressing addiction-related disorders.
Conclusion
The study highlights the ongoing opioid crisis, particularly in western Canada, where mortality rates are alarmingly high, largely due to increased fentanyl use. Individuals struggling with addiction require enhanced healthcare resources to succeed in overcoming these challenges. The findings suggest that collaborative care could be a valuable intervention for individuals seeking to reduce opioid and alcohol dependencies.
Written by Devang Nijsure, MSc
Reference: Watkins KE, Ober AJ, Lamp K, et al. Collaborative Care for Opioid and Alcohol Use Disorders in Primary Care: The SUMMIT Randomized Clinical Trial. 2017;2138:1-9. doi:10.1001/jamainternmed.2017.3947.